Welcome to our dedicated page for AXON ENTERPRISE SEC filings (Ticker: AXON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AXON ENTERPRISE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AXON ENTERPRISE's regulatory disclosures and financial reporting.
AXON ENTERPRISE, INC. president Joshua Isner reported equity compensation activity. On August 16, 2026 he acquired 67,910 performance-based restricted stock units (XSUs) tied to a tranche under the 2024 eXponential Stock Plan whose performance conditions were certified, which will vest on December 1, 2026 and then be subject to a minimum holding period. He also received a supplemental equity grant of 14,218 shares. On August 13, 2026, 15,704.08 shares were withheld at $615.59 per share to settle tax liabilities from vesting restricted stock units.
AXON ENTERPRISE, INC. reported that COO & CFO Brittany Bagley had two equity-related transactions in company common stock. On August 16, 2026, she acquired 30,560 performance-based restricted stock units (XSUs) for which the fourth tranche’s performance conditions were certified as met; this tranche is scheduled to vest on December 1, 2026, subject to continued employment, and the shares will be subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent tranche, excluding shares used for taxes. On August 13, 2026, 8,708.157 shares were disposed at $615.59 per share, representing shares withheld to settle her tax liability from vesting restricted stock units.
AXON ENTERPRISE, INC. reported that Chief Accounting Officer Jennifer H. Mak acquired 3,906 shares of common stock through settlement of performance-based restricted stock units (XSUs). These XSUs were granted on December 22, 2023 under the 2024 eXponential Stock Plan, with performance for the fourth tranche certified as achieved on August 16, 2026. The tranche is scheduled to vest on December 1, 2026, subject to continued employment, and the delivered shares will be subject to a minimum holding period. Following this award, Mak directly holds 13,755.968 shares of Axon common stock.
AXON ENTERPRISE, INC. reported that officer Elizabeth Reid Coughlin, Chief Human Officer, acquired 6,818 shares of common stock in the form of performance-based restricted stock units (XSUs). These units relate to a grant made on December 22, 2023, for which the fourth tranche’s performance conditions were certified as achieved on August 16, 2026. The tranche is scheduled to vest on December 1, 2026, subject to continued employment, and the shares will be subject to a minimum holding period extending to the earlier of December 31, 2030 or the vesting of a subsequent tranche. Following this acquisition, Coughlin holds 40,841.833 shares of Axon common stock directly.
AXON ENTERPRISE, INC. reported that Chief Legal Officer Isaiah Fields acquired 10,488 shares of common stock via vesting of performance-based restricted stock units (XSUs). These units were originally granted on December 22, 2023 under the 2024 eXponential Stock Plan after the Compensation Committee certified performance for the fourth tranche on August 16, 2026.
The tranche is scheduled to vest on December 1, 2026, subject to continued employment, and the resulting shares are subject to a minimum holding period until the earlier of December 31, 2030 or a subsequent tranche vesting, excluding any shares withheld or sold for taxes. Following this award, Fields directly holds 58,044.014 shares of Axon common stock.
AXON ENTERPRISE, INC. reported that Chief Revenue Officer Cameron Brooks acquired 15,810 shares of common stock through the certification of performance-based restricted stock units (XSUs) under the 2024 eXponential Stock Plan. These units relate to the fourth tranche, whose performance conditions were certified as met on August 16, 2026. The tranche is scheduled to vest on April 1, 2027, subject to continued employment, and the resulting shares will be subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent tranche, excluding any shares withheld or sold for taxes. Following this award, Brooks holds 67,980.933 shares of Axon common stock directly.
AXON ENTERPRISE, INC. reported that CEO and director Patrick W. Smith acquired 97,015 shares of Common Stock through performance-based restricted stock units tied to the fourth tranche of the 2024 CEO Performance Award. The Compensation Committee certified the performance conditions on August 16, 2026, resulting in this grant. Following the award, Smith directly holds 3,128,012 shares. These units will vest on December 31, 2029, subject to continued employment, and vested shares are subject to a minimum holding period extending until the earlier of December 31, 2030 or the vesting of a subsequent tranche, excluding any shares withheld for taxes.
Axon Enterprise, Inc., acting as an institutional investment manager, filed a Form 13F holdings report indicating that it manages one reportable position under the 13F reporting rules. The aggregate market value of this position is $19,126,190, based on the required reporting methodology.
The report lists no other included managers, meaning Axon Enterprise, Inc. is the sole reporting manager for these holdings in this filing.
Axon Enterprise, Inc. director and chief executive officer Patrick W. Smith reported a sale of 70 shares of common stock on August 7, 2026 at a weighted average price of $566.6186 per share, executed under a Rule 10b5-1 trading plan adopted on May 12, 2025. Following this transaction, he held 3,030,997 shares of Axon common stock directly.
AXON ENTERPRISE, INC. chief executive officer Patrick W. Smith reported open-market sales of a total of 9,930 shares of common stock on August 7, 2026. The 30 transactions were executed at per-share prices ranging from $526.5195 to $565.6468 pursuant to a pre-established Rule 10b5-1 trading plan adopted on May 12, 2025.